Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
94.56
+6.88 (7.85%)
At close: Jun 29, 2026, 4:00 PM EDT
92.67
-1.89 (-2.00%)
After-hours: Jun 29, 2026, 7:42 PM EDT
Monopar Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $101 | Buy | Maintains | $101 | +6.81% | Jun 29, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $105 | Buy | Reiterates | $105 | +11.04% | Jun 29, 2026 |
| Barclays | Barclays | Buy Maintains $125 | Buy | Maintains | $125 | +32.19% | Jun 29, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $130 | Buy | Maintains | $130 | +37.48% | Jun 29, 2026 |
| BTIG | BTIG | Buy Maintains $104 | Buy | Maintains | $104 | +9.98% | Jun 2, 2026 |
| Lake Street | Lake Street | Buy Maintains $103 | Buy | Maintains | $103 | +8.93% | Jun 1, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $115 | Buy | Maintains | $115 | +21.62% | May 18, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Reiterates $115 | Buy | Reiterates | $115 | +21.62% | May 15, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.